Clinical Trial Update: Effects of Growth Hormone on the Nitric Oxide Pathway [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating growth hormone's effects on the nitric oxide pathway in cardiovascular disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Hannover Medical School | Conditions: Cardiovascular Disease | Phase 1 | Status: COMPLETED